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ABSTRACT
Injury and degeneration of rotator cuff tendons are frequent causes of shoulder
disability globally, commonly affecting athletes and the elderly. Annually, there are
approximately 250,000 surgeries related to the rotator cuff performed in the United
States.1 With rotator cuff tears being the largest cause of rotator cuff surgery, between
10% and 40% of all rotator cuff tears are classified as massive, extending over 5 cm in
length. 2,3,4,5,6 The success rate of massive rotator cuff tear repair is variable, with re-tear
rates ranging from 38% to 90% depending on factors such as patient age, tear chronicity,
and overall tissue quality.7,8,9,10 A primary factor causing failure is poor tissue quality due
to poor tissue regeneration by sparse and inactive resident tenocytes.11 Current repair
approaches (biceps tenotomy/tenodesis, muscle-tendon transfer, and biologic tissue
grafts) suffer from shortcomings because they do not address tissue quality nor do they
attempt to regenerate damaged tendon.12,13,14,15,16,17,18,19 Therefore, it would be
advantageous to develop a therapy that can cause tissue regeneration by addressing the
issues of tenocyte inactivity and poor tissue quality.
Our proposed approach for massive RC repair utilizes autologous adipose derived
stem cells (hADSC) and an autologous tendon graft scaffold to biologically augment
suture repair by delivering stem cells and promoting their differentiation. This approach
aims to improve the quality of naturally formed matrix at the repair site over time through
integration of the scaffold with the damaged tendon. This method can be performed
entirely at the point of care, reducing additional processing time, external expansion of
cells, and tissue contamination. Herein, we propose to address proof of concept studies
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illustrating the following: 1) the ability to reliably form macro-porous (meshed) scaffolds
from a tendon source. 2) The viability of tenocytes within scaffolds. 3) The mechanical
properties of the scaffold. 4) The ideal autologous tenocyte source for differentiation of
hADSCs. 5) The ability of the scaffold-stem cell construct to integrate with underlying
tissue.
Results presented illustrate our ability to fabricate a macro-porous tendon scaffold
of 187% expansion and the properties of said scaffolds. Once scaffold fabrication was
established, the properties were assessed. When tendons were meshed to fabricate a
tendon graft scaffold cell viability was decreased by 30%, elastic modulus was decreased
by 32.45 MPa, and ultimate tensile stress was decreased by 1.82 MPa. The ideal tendon
source for fabrication of tendon graft scaffolds was determined to be semitendinosus
tendon over long head biceps tendon via hADSC differentiation profile. Lastly, in order
to determine if the scaffolds would improve the underlying tendon quality, the integration
of the proposed construct was illustrated in vitro.
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CHAPTER ONE
LITERATURE REVIEW
1.1 Shoulder Anatomy
The shoulder consists of three bones, the clavicle, the scapula, and the humerus. The
moving joint of the shoulder, the glenohumeral joint, is a ball-in-socket joint connecting
the head of the humerus at the glenoid fossa of the scapula.20 Additionally, the clavicle is
attached to the scapula at the acromion via a plane-synovial joint allowing for
significantly less motion than the glenohumeral joint.

Figure 1: Illustration of the bony anatomy of the right shoulder, viewed from the
posterior.
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The rotator cuff is a series of four muscles connecting the scapula to the proximal
humerus. The tendons of the rotator cuff are present at the humeral interface of the
muscles. The supraspinatus tendon is located on the superior surface of the greater
tuberosity of the humerus. The infraspinatus tendon is located on the posterior-superior
surface of the greater tuberosity of the humerus. The subscapularis tendon is located on
the anterior surface of the lesser tuberosity of the humerus. The teres minor tendon is
located on the posterior-inferior surface of the greater tuberosity of the humerus.2 The
muscles of the rotator cuff provide stability to the glenohumeral joint in normal
movement such as rotation, elevation, and abduction. Additionally, the location of the
subscapularis prevents anterior translation of the humeral head.

Figure 2: Image of the rotator cuff tendons of the right shoulder shown from the medial
view at their insertions onto the humerus.21
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In vertebrates, tendon is a tissue that connects muscle to bone. During muscle
contraction, the tendon allows for force transfer to the bone resulting in movement of the
musculoskeletal system. Due to this role, tendons are often under high levels of tensile
stress. As their form follows their function, tendons are a highly aligned dense connective
tissue made up of strong aligned collagen in the direction parallel to the applied forces
between the muscle and bone. As a dense connective tissue, tendon has a high matrix to
cell ratio.

Figure 3: Hierarchical structure of the tendon microstructure. Sub-fibrils in this image are
known as fibrils and fibrils are then known as fibers.22

Tendon extracellular matrix, ECM, has a hierarchical structure similar to that seen
in muscle structure (Figure 4). At the smallest level, individual molecules of Collagen I
wind together to form a tropocollagen molecule. Bundles of aligned tropocollagen
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molecules form fibrils, which can be full millimeters in continuous length and anywhere
from 50 to 300 nm in diameter. Fibrils of all sizes are collected together into a larger fiber
and a surrounded by the endotendon sheath.23 The endotendon is comprised of uniform
and thin (50 nm) collagen microfibrils arranged helically along the length of the tendon.
Fibers, along with tenocytes that align themselves with the fibers are bundled into
fascicles that are then bundled again into the total tendon.24,25,26 Fascicles are surrounded
by the epitendinous sheath, which they are then combined and surrounded by the
peritendinous sheath to form the whole tendon. The peritendon sheath is made up of the
same helical microfibrils as the endotendon, but the peritendon is made up of more
variable thickness, straight microfibrils.23 Within the ECM of tendons, 60% to 85% of the
dry weight is composed of collagen.22 Collagen I is the major collagen component,
making up 95% of the collagen, with lower levels of other collagen types Collagen III, IV,
and V.27 Collagen III is frequently seen in tendons, especially when they are repairing
from damage as the thinner fibers are more quickly produced to repair an injury site. Riley
et al. saw a correlation in an increase in Collagen III presence in damaged rotator cuff
tissues compared to macroscopically healthy tissue in correspondence with a slight
decrease in Collagen I content. The other proteins present in the ECM are various types of
proteoglycans, glycoproteins, and glycol-conjugates with differing purposes for the
function of the tendon. The most abundant type of proteoglycans within the tissue is a type
of small leucine-rich proteoglycan (SLRP) called decorin. Decorin makes up
approximately 80% of the proteoglycan content of the tendon. SLRPs found in lesser
quantities include biglycan, fibromodulin, and lumican.22,28 All of the SLRPs share similar
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end functions in modification of collagen fibrils during assembly and maintenance of
tendon integrity. Decorin specifically has been implicated in facilitating the formation of
collagen crosslinks during fibril formation.29,30 Large aggregating proteoglycans are a less
commonly found type of proteoglycan within tendon, but they are present in the forms of
versican and aggrecan. These proteoglycans increase the water content of the tissue
resulting in a higher compressive strength, and are therefore often found regionally in
areas of tendon where compression is more commonly experienced. Glycoproteins of
tendon include lubricin, collagen oligomeric matrix component (COMP), tenascin-C, and
tenomodulin. COMP has been shown to promote collagen-to-collagen binding, and
therefore work with the SLRPs to promote collagen fibril assembly.28 Tenascin-C is
present in the interfibular matrix with COMP and the SLRPs but is most prevalent within
immature tendon. Tenomodulin has been shown to be a regulator of cellular proliferation
and adherence to the ECM.31 Lubricin is thought to, along with elastin, be the enabling
factor in sliding and recoil between fascicles as well as being present in the epitendinous
sheath surrounding the tendon body.23 Both proteins are present within the endotendinous
matrices, which are less dense and collagenous than the tendon body itself, allowing for
mechanical distribution throughout the tendon.
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Figure 4: Histological image (H&E) of tendon, illustrating fiber and cellular alignment.
Nuclei are dark and extracellular matrix is stained pink.

The cells within tendon, tenocytes, are sparse compared to other tissues but remain
aligned with the collagen fibers of the matrix. Tenocytes make up less than 5% of the total
volume of tendon tissue.32 Tenocytes are not characterized by one specific marker, but by
an array of markers and morphological qualities. Similarly to fibroblast, of which
tenocytes are often considered a derivative, tenocytes are elongated and characteristically
spindle shaped. Cell markers that are known to be present on tenocytes include Scleraxis
B (SCX), Tenascin C (TNC), Tenomodulin (TMD), Collagen I (COL1), and Collagen III
(COL3).
In 2010, Pauly et al. investigated tendon cell cultures as a way of understanding
tendon biology on a fundamental level.33 They screened cells for markers of collagen I,
collagen III, decorin, biglycan, aggrecan, tenascin C, scleraxis, tenomodulin, collagen II,
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and osteocalcin. Comparing collagenase isolated rotator cuff tenocytes to osteoblasts and
chondrocytes, they sought to determine what markers were indicative of the tenocyte
phenotype. In terms of markers, no singular marker was shown to be a clear indicator of
tenocytes. Scleraxis was shown in differing levels in all cell populations, as well as
tenascin and tenomodulin. It is therefore important to show the combination of these
markers with collagen I and collagen III in the correct ratios in order to determine if a cell
population contains tenocytes.

1.2 Clinical Significance of Rotator Cuff Tears
Injury and degeneration of the rotator cuff tendons are frequent causes of disability with
approximately 250,000 surgeries related to the rotator cuff performed annually in the
United States.1 The most common surgical procedure of the shoulder is the rotator cuff
tear repair. Rotator cuff tears may occur acutely or chronically. Acute injury of the
tendons often occurs in younger patients due to rapid, forceful movement such as those
found in athletes. When an injury persists over an extended period of time or a small
injury gradually increases in severity over time due to repeated functional movements, a
tear is classified as chronic. Chronic tears are often found in the elderly and result in
gradual degeneration of the tendon tissue and inflammation at the injury site. Rotator cuff
tears can be categorized by many methods. A tendon tear may be graded as full or partial
thickness, either penetrating part or all of the way through the tendon respectively.
Partial tears are simpler to repair as they retain some connection between the tendon
edges and humerus and do not require tensing the edges together to repair. A full
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thickness tear is then often classified again by size. Two methods of classification are the
Colfield and Bateman methods.3 Both classified tears by their length torn from the
humeral head in the anterior-posterior direction. Colfield classified tears at the time of
surgery a small tear as less than 1cm in length, medium as 1-3cm, large as 3-5cm, and
massive as greater than 5cm.2,4,5,6 Bateman, however, in a slightly less commonly used
system graded the tears after surgical debridement as Grade 1 for less than 1cm in length,
Grade 2 for 1-3cm, Grade 3 for 3-5cm, and Grade 4 for a global tear with no remaining
cuff left after debridement. Massive tears, as classified by Colfield, account for between
10% and 40% of all full thickness rotator cuff tears.4 Unfortunately, within massive
rotator cuff tears, repair failure occurs at a rate of 38% to 90% depending on factors such
as patient age, tear chronicity, and overall tendon quality.7,8,9,10 The most common
method seen of re-tear after rotator cuff repair surgery, regardless of patient age or suture
anchor method used, is suture tear through at the suture-tendon interface.34 This
exemplifies that re-tear is highly effected by tendon quality, which is reduced by cellular
senescence of resident tenocytes. Cellular senescence is a state in which the cell cycle is
arrested and is unable to be reactivated leading to poor proliferation and survival.11
Senescent cells have been shown to express high levels of matrix metalloproteases
(MMPs), a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS),
and pro-inflammatory cytokines. MMPs and ADAMTS are cytokines that break down
collagen and proteoglycan molecules respectively, thus causing overall matrix
breakdown. Pro-inflammatory cytokines upregulate inflammatory reactions in the tissue.
In tenocytes, cellular senescence can occur due to aging or, in younger patients, due to
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injury. Due to the high instance of re-tear in some surgical conditions, specifically in
chronic and massive rotator cuff tears, a complete rotator cuff repair is not always
possible. Talbot et al. discussed the theory of extrinsic tear, or impingement, where
damage is caused by repetitive micro-trauma under the acromion. Intrinsic theory
considers degeneration of the rotator cuff with age, with relative de-vascularization of the
tendon making the cuff more prone to injury.11,12,27

1.3 Current Treatment Options for Rotator Cuff Repair
The most common surgical procedure of the shoulder is the rotator cuff repair. The
repair begins with debridement of the torn tissue ends, the tendon end to remove dead
tissue, and the bone insertion to remove dead tissue and stimulate the cancellous bone to
bleeding in order to stimulate bone marrow. Suture anchors are drilled into the bone to
affix the suture to the bone side of the repair. Multiple suture anchors can be used,
depending on the size of the tear. Suture is used to connect the two sides of the repair
using single or multiple rows, simple or mattress style knotting methods.35
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Figure 5: Image of suture repair methods for rotator cuff repair. A) Suture anchors within
the humeral head. B) Double row simple suture configuration. C) Double row mattress
suture configuration.36

Tension is then applied across the suture to tighten and close the gap between the
tendon and bone. This may be difficult in larger tears as less tissue is remaining to cover
the area previously spanned by the tendon, resulting in an increased tension applied to the
remaining tendon. Rotator cuff surgery may be performed either open or arthroscopically
within the joint, however with an increase in size of tear surgeons may choose to perform
an open surgery more often than an arthroscopic one.36,37,38 In 2012, Colvin reviewed
national trends in rotator cuff repair and how they have changed from 1996 and 2006.13
58,846 and 272,148 repairs were performed in those respective years. They compared the
data between those years on the basis of procedure type, open and arthroscopic, age of
patient, and inpatient vs. outpatient procedures. They saw an increase in outpatient
procedures in 2006. Arthroscopic procedure numbers increased significantly in 2006
especially for those patients between 45 and 64 and over 65. More patients over 65 were
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also having open procedures, but less were having them in the 45-64 age group and only
slightly more under 45. Generally they noticed that old age was associated with the
increased prevalence of RC tears but that surgeons have become more aggressive with
early repair. Massive tears have been more often seen in older patients, as they have had
more time to degenerate to a larger form.
There is also an option to avoid surgery and seek physiotherapy. Physiotherapy
consists of a series of exercises to correct upper body posture and to improve
scapulothoracic and glenohumeral muscular control and stability. In 2014, Moosmayer et
al. reported on a study in which 103 patients were subjected to surgical treatment (open
or mini open) (52) or physiotherapy (51) for rotator cuff tears.14 The tears were full
thickness but less than 5cm in length. The physiotherapy exercises were performed for 40
min 2 times weekly for 12 weeks. 12 patients chose to have surgical repair after seeing
insufficient effects from physiotherapy. Results were better in the primary tendon repair
group but differences between the surgical repair groups were small. Constant score, or
the reported comfort and functionality, was significantly higher in primary tendon repair
group compared to physiotherapy only. When compared to secondary repair, the
difference was not significant. 38 physiotherapy patients saw an increase in tear size of
less than 5mm and greater than 5mm in 14 cases. Full thickness re-tear was seen in 8 and
partial thickness re-tear in 7 of the surgical cases. So, when comparing results between
surgical and physiotherapy interventions, surgery seemed to have the better patient
outcome. However, if other physiotherapy methods are found over time that surpass the
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quality of the ones used by Moosmayer and his team, this study would have to be reanalyzed with the new exercise options.
In 2012, George et al. looked at the causes, complications, and approaches in
healing small and medium size tears after failed rotator cuff repair.39 They noted that
failed repairs were usually due to multiple factors including surgical complication,
diagnostic errors, hidden lesions, technical errors, and poor tissue. The overall surgical
complication rate was 10% from factors such as failure of the deltoid, infection, foreign
body reaction, stiffness, and neurologic injury.

Diagnostic errors, such incomplete

diagnoses were shown to be a cause of some instances of re-tear. Additionally,
supraspinatus tears were shown to have hidden lesions of the rotator interval, long head
biceps tendon, or subscapularis. Technical errors in repairing specific tear shapes can
cause re-tear as there are many tear shapes that may present difficult in a rotator cuff
repair such as crescent, u-shaped, l-shaped, or massive contracted immobile. However,
regardless of other factors, re-torn cuff tissue is usually of poor quality with increased
muscle atrophy and fatty infiltration. Authors suggested augmentation of repairs when
tissue quality is found to be poor or lacking.
Due to high re-tear rates and a relatively low amount of reparable tissue, chronic
massive rotator cuff tears are often deemed irreparable and not operated on. In these cases,
physical therapy for strengthening of the surrounding muscles is often used to retain some
shoulder function. Talbot et al. looks at the other options for dealing with massive rotator
cuff tears that are deemed irreparable.12 Patients with massive irreparable rotator cuff tears
present with variable function and pain. Tendons that cannot be mobilized to repair are
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considered irreparable. Non-operative management of these tears includes analgesics,
steroid injections, and activity adaptations.15 These management methods, however, have
not been shown to alter the eventual degenerative course of a chronic tear.16 Deltoid “reeducation programs”, where patients have used physical therapy to train the deltoid to
function in place of the torn muscle, have shown marked increases in Constant scores,
especially within the elderly. Operative options that are not complete rotator cuff repairs
include simple debridement of dead tissue, subacromial decompression, and biceps
tenotomy. These options reduce the amount of extra degenerating tissue in the injury area
and often show reduction of pain, though do not cause a change in function.16 In
subacromial decompression, the tissues in the capsule under the acromion are released to
increase the range of motion of the join and reduce the likelihood of impingement. Biceps
tenotomy also reduces pain by removing the long head of the biceps tendon and freeing
that area from additional wear and inflammation.17,18,40 The short term pain reduction
benefits of any of these methods may not be retained over time. Supra-scapular nerve
ablation showed improvements in pain scores that were not maintained over 3 months by
desensitizing the nerve. Partial rotator cuff repairs focus on reinforcing mechanical
properties rather than repairing anatomical structure. Tendon transfer surgeries (latissimus
dorsi, deltoid) aim to restore function in younger and higher demand patients. These
surgeries remove the tendon and muscle from their original insertion and replace them at
the torn rotator cuff insertion, where their contraction then functions to move the shoulder
rather than their original purpose.19 Functional scores increase about 25% after surgery but
loss of strength is not corrected and loss of functionality is present at the site of the

13

removed tendon-muscle pair. Augmented repairs are often used, but there are many
options that require more study. Arthroplasty, or shoulder joint replacement, is a last ditch
solution and does have high benefits when successful. However it can wear over time in
young patients and has a variable success rate especially in those with previous shoulder
surgery.

1.4 Tendon Tissue Engineering
Tissue engineering in application for rotator cuff repair is the manipulation of
cells, scaffolds, and tissues to repair and hopefully regenerate the tendon tissue in the
rotator cuff back to a pre-torn state.

1.41 Scaffolds
In the repair of tendons, including rotator cuffs, there is often a need for
augmentation of the original tissue if that tissue is damaged or removed due to injury or
disease. Scaffolds are a material used to augment tissue, provide a delivery environment
for cells, and provide signaling for healing. Scaffolds can act as a replacement for that
tissue either in temporary or a long-term state. Some scaffolds are used to off-load the
tissue at the repair site from experiencing excess tension by acting as a mechanical
augmentation while others may act to help guide the healing of the repair site through
biological augmentation. In biological augmentation, scaffolds can act as a delivery
vehicle for chemicals, growth factors, or cells to the repair site.
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Scaffolds can be biologically or synthetically based, being made from protein
extracellular matrices or synthetic polymers respectively. Advantages attributed to
biological scaffolds include having a well-defined 3D surface protein microstructure and
a natural porosity.41 They can quickly interact with host tissue and induce new tissue
formation faster than synthetic grafts. Limitations of these grafts include relatively low
mechanical properties, non-specific induction, undefined degradation, and variable
biocompatibility compared with synthetic materials. Synthetic scaffolds are manufactured
from chemical compounds, allowing control of chemical and physical properties, higher
mechanical strength, and consistent quality. However, synthetic materials often come
with poor biocompatibility and a lack of integration potential.
In 2010, Longo et al. performed a systematic review of the most commonly used
biological and synthetic grafts for tendon on the market at the time. The review gave a
brief overview of the products’ benefits and drawbacks found for the rotator cuff area.41
Biological scaffolds are usually small intestine submucosa (SIS), dermis, or pericardium
and are de-cellularized. Figure 5 shows the table of grafts analyzed in the article.
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Table 1: The most popular commercially available grafts as analyzed by Longo et al.
(2010).41

In the lab, SIS has been shown to have poorer results than autologous implants.
However, some success was seen with cell seeding on said grafts. Collagen patches
tended to cause high inflammation. PLA patches also did not see significant load
increases. Additionally, in a clinical study patients with xenografts had less strength than
control repairs, more impingement of rotation, and slower healing rates, specifically with
SIS that was shown to not be fully de-cellularized as claimed by the manufacturers.
GraftJacket, human dermal matrix, showed increased strength, and statistically significant
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improvements in pain, forward flexing, external rotation, and full graft incorporation in
13/16 patients in clinical trial. In terms of synthetic grafts, polymer filamentous carbon
composites and BMSC cell seeded knitted PLGA fiber scaffolds showed good
histological and mechanical outcomes and a higher volume of regenerated tissue, higher
tensile stiffness, and higher modulus compared to non-seeded controls respectively. The
authors noted after these reviews that both fiber alignment and cellular seeding showed
benefit in grafting, in addition to full de-cellularization of xenogenic materials.
Other types of scaffolds are still under investigation, such as those reported on in
2015 by Alberti et al. The researchers use a technique they call “bioskiving” to create
scaffolds from de-cellularized tendon.42 They cryosection de-cellularized tendon into
50um thick slices, stack them while frozen, and then air dry to fuse the stacks. The dried
tendon stacks are then washed in 5% glutaraldehyde and PBS for 30 minutes and air
dried again before use. Alberti and his team investigated the effects of section orientation
and glutaraldehyde crosslinking concentration on tensile strength of the scaffolds
produced. Non-crosslinked samples had the lowest UTS and modulus values. They also
showed sliding of fibers in the midsection. 2.5% glutaraldehyde for 20 min resulted in the
highest UTS value and a modulus. According to scanning electron microscopy (SEM)
imaging, non-crosslinked samples fail with smooth edges as if the failure occurred by
adjacent fiber pull apart, whereas crosslinked samples fail at a rough edge where fracture
may have propagated and ended fibers on a micro scale. When force was applied along
the direction of the fibers (0 degrees), the UTS was the highest. When force was applied
at 45 degrees and 90 degrees (perpendicular) the UTS values fell with an increase in
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angle.

The moduli followed the same trend. When fiber angle was alternated, the

strongest samples other than samples that were all aligned had were aligned at 45
degrees.
The methods of using grafts are still under research to determine the most
beneficial application of grafts for rotator cuff augmentation. In 2012, Mihata et al.
looked to cadaveric models to determine the best of 3 tested patch-grafting methods. The
three methods were tendon reconstruction, capsule reconstruction, and a method that
includes both (hybrid).43 The grafts were made from fascia lata of allografts that was
about 5mm thick when folded 2 to 3 times and sutured at the open edge. Lengths and
widths of the grafts were best matched to lengths and widths required for repairs.
Balanced load and superior force tests were performed with a total of 110 N distributed.
Under superior force, the tendon repair resulted in a significant superior translation.
Under capsule and hybrid repairs, the translation was not significant, nor was the
difference between the movement of capsule and hybrid repairs. Capsule reconstruction
reduced the range of motion by 16 degrees, and there was not a significant difference
between that and hybrid. Glenohumeral force was not restored by any of the methods
tested.
In 2008, Moffat et al. developed an electrospun poly(D,L-lactide-co-glycolide)
(PLGA) polymer scaffold for rotator cuff repair.44 They used electrospinning to create
aligned nanofibers on which they then cultured rotator cuff fibroblast-like cells for 3 and
14 days. Gene expression of collagen type I appeared after 3 days of culture whereas
collagen type III expression remained the same in aligned matrices, non-aligned matrices,
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and monolayer controls across all timepoints. Mechanically, in vitro culture decreased the
ultimate tensile stress (UTS) and yield strength of the scaffolds over time when they were
not seeded with cells. However, the application of cells caused the mechanical changes to
halt, resulting in no significant changes to mechanical properties over time. Additionally,
at all time points, the aligned scaffolds had greater tensile properties than those that were
not aligned in both cellular and acellular groups.
In 1998, Young et al. studied the use of collagen gel as a scaffold for delivery of
stem cells to an Achilles tendon defect.45 They created a construct from bone marrow
derived stem cells and type I collagen derived from bovine skin by suspending the cells
in the collagen solution and then gelating it between two sutures. The sutures were then
used to implant the constructs into the Achilles tendons of rabbits after 40 hours of
culture. After 4, 8, or 12 weeks, the tendons were mechanically tested. Samples with the
constructs measured higher on average for stiffness, maximum force, modulus, maximum
stress, reaction force energy, and failure energy at every time point than suture repaired
controls. The constructs also exhibited aligned and elongated cell morphology within the
repair as compared to variable morphology within the controls. These results supported
their initial hypothesis that cells and an organized collagen matrix would improve repair
biomechanics.
In 2014, Pawelec et al. looked at the influence of fibrin gel on the morphology
change of tenocytes.46 Fibrin is a gel that does not inhibit ECM formation. In Pawelec’s
study, gel was made using 1% fibrin and aprotinin (.15 U/ml) in PBS. Gelation occurred
by immersion in 300ul of 0.4 U/m thrombin for 10 min. Samples of tenocytes were either
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plated alone, with fibrin gel, or with fibrin gel on type 1 collagen scaffolds. Metabolic
activity of cells was seen to increase with the addition of fibrin gel. Fibrin gel on
scaffolds yielded the highest number of cells, scleraxis expression, and tenomodulin
expression. The addition of fibrin gel did not cause an increase in COL1 production when
normalized to cell number. This study showed the benefits of applying physiological
proteins for the expression of tendon properties but that mechanical support via a
scaffolding or graft system proves more beneficial than unsupportive proteins.
In 2014, Beitzel et al. compared highly crosslinked collagen, non-crosslinked
collagen, and fibrin matrices to human rotator cuff tendon.47 They loaded them with bone
marrow derived stem cells and performed cell adhesion, proliferation, histology, and
scanning electron microscopy (SEM). They determined that greater numbers of cells
adhered to the non-crosslinked and fibrin scaffolds compared to the samples. Noncrosslinked collagen samples saw higher proliferation rates compared to fibrin but no
significant differences with other scaffolds. In histological analysis, cells adhered to the
edges of all scaffolds. Both collagen membranes allowed cellular migration into the
center of the scaffold. However, the rotator cuff tendon showed the highest number of
cells compared to the highly crosslinked collagen and the fibrin. Using SEM, porosity
was measured, showing that rotator cuff tendon has 20-30% porosity, while noncrosslinked collagen was 60-70% porous. These differences were attributed to the
varying matrix components and constructions, indicating the necessity of tailored matrix
properties to match those found in rotator cuff tendon.
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In 2010, Sano et al. reported on a clinical study in which 20 patients underwent
repair of massive rotator cuff tears with long head biceps tendon grafting in order to
study the repair integrity.48 The protocol used in this paper included the removal of the
long head biceps tendon (LHBT) by tenodesis and splitting the tendon graft into two
layers width-wise if it was smaller than the residual defect. The graft was attached to the
original cuff tendon with suture that then snaked through the patch tendon and ended at a
bony insertion. 14 of the 20 patients followed up for analysis after 12 to 48 months. They
were analyzed via Japanese Orthopaedic Association (JOA) shoulder scores which
monitored levels of shoulder pain, range of motion, muscle strength, muscle durability,
and ability to perform activities of daily living.

All JOA parameters increased

significantly on average after follow up. Repair types shown Radiologically, 13 patients
showed no re-tear and 1 showed a minor discontinuity. Of the 13 without re-tear, 3
showed sufficient thickness of repair and 10 showed no discontinuity but insufficient
thickness compared to a healthy tendon. Though the study size was small, the results did
show results of a decrease from normal re-tear rates with the application of the graft. The
insufficient thickness, however, indicates that additional help would be required to bring
the cuff back to a healthy state on a reliable basis.

1.42 Cell Sources
As tendons have a low cell density and damaged tendons have less active resident
tenocytes, the application of an alternative cell source is often required for tissue
engineering. When a healthy alternative cell source is applied, active cells are then
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present to re-build the damaged matrix to a one more fitting of the healthier cells. This
can result in a final tissue with mechanical and chemical properties more similar to an undamaged tissue.
In 2015, Gungormus et al. performed a study to determine if cells would improve
the effects of a graft in a tendon repair situation. They compared allogenic de-cellularized
tendon matrix with allogenic re-cellularized matrix for implantation into an Achilles
defect model in rats.49 They removed Achilles tendons from rats and de-cellularized
them, either than re-seeding them with tenocytes or leaving without cells. Surgically,
both Achilles tendons were operated on in each rat. Rats received either a repair using
normal suture technique, de-cellularized ECM or re-cellularized ECM. Groups were
assessed at 2,4,6,8,12, and 24 weeks for histopathological and biomechanical analysis.
Histopathologically samples were studied for inflammatory cell concentration, cell
number, cell distribution, ECM organization, collagen fiber alignment, and metaplasia.
Within each week and each criterion studied the re-cellularized ECM group performed
best, achieving most successful structural tendon recovery and results more closely
mimicking healthy ECM. Biomechanically, re-cellularized ECM had a significantly
higher UTS than de-cellularized ECM or suture repair. With any scaffold application,
stiffness increased over time. This study showed the benefits of combining cells and
scaffold for the repair of tendon tissue toward a healthier morphology and strength.
Stem cells are most simply defined as cells that have the capability to replicate
indefinitely and differentiate toward many different final tissue types. Within the adult
body, there are populations of stem cells present in various tissue types. These are known
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as adult stem cells. As adult stem cells, they do have more limited differentiation potential
as compared to embryonic stem cells, which are able to differentiate into all cell types. An
adult stem cell is said to be pluripotent, or able to differentiate into many cell types, and
can be know as a mesenchymal stem cell (MSC) or hematopoietic stem cell (HPSC).
MSCs can differentiate into osteoblasts, chondrocytes, myocytes, stromal cells,
fibroblasts, tenocytes, adipocytes, and dermal cells. HPSCs differentiate into blood cells
and lymphocytes. MSCs are used in tendon treatment due to their differentiation potential
and their homeostatic properties in tendon. The homeostatic properties most beneficial in a
damaged tendon environment include anabolic effects on paracrine signaling, direct antiinflammatory

effects

on

surrounding

cells

through

chemokine

upregulation,

chemoattraction of other local cells for repair, and anti-apoptotic effects.50 Commonly
used sources of MSCs include bone marrow (BMSC) and adipose tissue (ADSC). Both
cell types have been shown to express the requisite adult stem cell markers such as CD10,
CD13, CD73, and CD105.51,52
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Figure 6: Graphic of the differentiation lineages of mesenchymal stem cells.53
BMSCs are studied frequently in literature for their differentiation capabilities
towards many lineages and are also used in combination with the hematopoietic bone
marrow stem cells in bone marrow transplants after radiation to regenerate the bone
marrow for a source of immune cells and cells for restoration of other tissues. A bone
marrow aspirate, usually taken from the iliac crest of the pelvis, is removed, centrifuged to
concentrate the cells, and then either expanded in vivo to produce more or used
immediately. BMSCs are very well characterized as stem cells and have been used for
much longer than ADSCs. There is a limit, however, to the amount of bone marrow that
can be extracted from aspiration site of which 0.01% to 0.001% of cells are BMSCs.54,55
ADSCs are isolated from adipose tissue, which is more accessible and abundant than bone
marrow with 1% to 10% of cells being ADSCs.53,56,57 Lipoaspirate or adipose excision is
taken and, in the case of the whole tissue excision, broken down by collagenase digestion.
The resulting liquid is then spun using density gradient centrifugation wherein layers of
differential density separate from the suspension and can be isolated.53 The cell pellet
obtained is termed the stromal vascular fraction (SVF) and contains the ADSC population.
Cells can then be plated for expansion or used immediately. Although the concentration of
ADSCs within adipose tissue remains relatively low, the ability to retrieve additional
tissue and reduce surgical pain compared to a bone marrow aspirate has researchers
considering this option.
In tendon tissue engineering, differentiation of stem cells allows for the creation
of a newly active tenocyte population. Since tenocytes become less metabolically active
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as they age, creating a young tenocyte population via differentiation is a good way to
increase the matrix production capacity of the tenocyte population as well as increasing
the size of the population in general.58,59
In 2013 Kraus et al. showed the tenogenic differentiation potential of ADSCs by a
co-culture of human flexor tenocytes and ADSCs.60 They used direct co-culture in 3:1,
1:1, and 1:3 ratios of tenocytes to stem cells, indirect co-culture in those same ratios, and
media conditioning. All differentiation studies were performed over 10 days. Media for
conditioning was taken from 70-90% confluent tenocytes cultured for 24 hours in said
media. It was then fed at a 1:1 ratio with fresh media to ADSCs. They used IHC and PCR
for tendon markers Collagen I, Collagen III, Scleraxis B, Tenascin C, Elastin,
Tenomodulin, and C-FOS to determine differentiation and to determine which markers
best indicated tenogenic differentiation. In direct co-culture, they saw 3.3 to 3.6 fold
increase in Tenascin C (TNC) expression depending on ratio. Scleraxis B (SCX) was upregulated 1.5 fold in 1:3 ratio. They also noted that proliferation was higher with higher
ratios of stem cells to tenocytes. For media conditioned cells, TNC was up-regulated 2.5
fold and Collagen III (COL3) was up-regulated 1.4 fold. There was no up-regulation seen
in other markers. In the indirect system, TNC was up-regulated 2.3 fold. Overall TNC
and to a lesser extent SCX and COL3 were shown as good tendon markers, with 1:3 ratio
yielding higher differentiation. However higher ADSC levels were shown to yield higher
proliferation in this study.
In 2011 Gulotta et al. sought to determine if using SCX transduced BMSCs for
rotator cuff augmentation would improve tendon quality in healing, specifically at the
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bony insertion.61 To transduce the cells they used and adenoviral vector to add the coding
for SCX to the existing genome of the BMSCs and determined that SCX expression was
115-fold higher in transduced cells than in normal cells. They performed an in vivo rat
study for repair of the supraspinatus tendon with injection of BMSCs. Animals received
either transduced or natural BMSCs but there was no natural control used. Histology was
performed at 2 and 4 weeks using H&E, safranin-O/fast green, and picrosirius red. At 2
weeks, there was no statistical differences seen, but at 4 weeks there was an increase in
fibrocartilage at the interface. Biomechanical tensile testing was preformed at 2 and 4
weeks under a 45N load cell. The samples were pre-loaded to 0.1N, loaded at a rate of 14
microns/s until repair failure. All samples failed at the tendon-bone interface. At 2 weeks
there were increases in UTS and stiffness with SCX compared to non-SCX MSCs. At 4
weeks, UTS, stiffness, and ultimate load were all higher in the SCX augmented group.
These results indicated that the fibrocartilage interface between the tendon and bone did
increase in size over time with SCX augmentation, and that the repair strength also
increased with SCX augmentation. This study used a know gene for tendon ECM protein
scleraxis to directly effect BMSCs and resulted in increased strength in healing at the
tendon-bone interface after 4 weeks.
In 2014, Hernigou et al. performed arthroscopic rotator cuff repair on 90 patients
applying concentrated autologous BMSCs to the repair via injection in 45 patients.62
Patients were limited to those with tears of the supraspinatus alone and a full thickness
tear size of 1.5 to 2.5 cm in diameter. Control patients were matched for tear size, rupture
location, dominant shoulder, gender, and age. These control patients were taken from
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patients who had the same repair without BMSCs prior to 2000. In the BMSC procedure
150mL of marrow was isolated and then concentrated down to 12mL. The repair was
performed via a single row repair using suture anchors to the abraded lateral edge of the
humeral tuberosity. 4ml of BMSCs were injected between the bone and tendon and 8mL
were injected into the bone at the site of the footprint. The number of cells injected was
recorded for each surgery and averaged 4300±1800 cells per milliliter. At the 10 year
follow up mark, 39/45 (87%) of BMSC patients had intact rotator cuffs and 20/45 (44%)
of control patients had intact cuffs. Control patients were found four times more likely to
have re-tear. The BMSC group had poor or no healing in only 1 tendon (supraspinatus
tendon), but the control group had 6 cases involving supraspinatus and infraspinatus that
failed to heal, and 4 cases involving all 3 tendons. Within the BMSC group, the 6 failed
tendons were seen to have significantly lower concentrations of BMSCs applied in the
graft than the average (1500±1200 vs. 4200±1900). Size of tear, age at surgery, and
time between diagnosis and repair were predictive of deficient healing in the
control group but not in the BMSC applied group. There was a negative correlation
found between the concentration of BMSCs within a graft and the time to obtain
total healing, meaning that an increase in BMSC concentration decreased time to
healing. Tears larger than 2cm required an average of 6 months, rather than 3
months for those smaller than 2cm. Regardless of tear size, control group samples
took an average of 2 months longer to reach total healing than the BMSC group.
In 2015, Skoff reported on a technique for rotator cuff reconstruction using
autologous biceps tendon grafts and BMSCs.63 He performed the surgery ten consecutive
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patients with large retracted rotator cuff tears and a history of prior rotator cuff repair.
The surgical technique included aspiration of iliac bone marrow (60mL) and
concentration 4 to 5 fold via centrifugation (10mL). This created a concentrated solution
of PRP and MSCs. LHBT was harvested and cut 50% in depth longitudinally and splayed
to flatten the tendon. The graft was then incubated in the PRP/MSC solution for 60
minutes prior to implantation. The graft was attached to the bone and then to the damaged
tendon. The remaining PRP/MSC solution was injected deep and superficial to the
construct prior to closure. The patients reported increased in Constant, ASES, and UCLA
scores for pain and functionality. At 12 months following surgery, ultrasound showed
that the graft was still intact within the cuff but continuous with the adjacent tendon. At
44 months the graft was no longer visible and showed evidence of integration with the
surrounding tissue. No incidence of full thickness re-tearing was reported for any of the
patients in this study.

1.43 Growth Factors
Often, growth factors are indicated as necessary for the differentiation of stem
cells and for the triggering of resident cells toward creating new matrix. Within tendon,
this has been studied as a method for tissue engineering in which growth factors are
applied to effect either the cells that are present at the application point or cells that are
co-applied with the growth factors for repair. Growth factors are proteins excreted by
cells in specific sequence in order to trigger surrounding cells to follow a certain biologic
path. Insulin growth factor-1 (IGF-1) is a commonly studied growth factor that is
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upregulated in tendon during inflammation. IGF-1 induces chemotaxis of neutrophils and
fibroblasts to an injury site for repair. It also can induce collagen synthesis during the
remodeling of tendon ECM.64 Basic fibroblast growth factor (FGF), is secreted by
fibroblasts that arrive at the repair site and stimulates cellular proliferation as well as cellmatrix interactions.65 Additionally, growth differentiation factor (GDF) also plays a role
in cellular proliferation and increase of collagen synthesis. GDF also specifically
improves the alignment of collagen fibers by way of organization and assists in
transcription of tendon specific genes.66
In 1999, Kurtz et al. studied how IGF-1 contributed to tendon healing in rats in
terms of healing acceleration.67 The researchers intended to use the growth factor as a
therapeutic agent to positively modify the repair process. The tendon was transected and
sutured closed. IGF-1 was injected or not injected depending on the study group.
Biomechanical tests were performed with a 0.5 N preload at 1cm/sec to failure. Failure
load, deformation, and stiffness were determined. Inflammation was determined by
quantification of invading neutrophils. Mechanically, at 15 days there was no significant
difference seen between failure loads but there was a trend toward increased deformation
in the operated tendons compared to sham controls. Stiffness was reduced in operated
groups compared to sham controls, but there was no difference between treated and
untreated groups. Neutrophilic invasion was no different between groups, and IGF-1 did
not affect the cellular component or the cell number of the inflammatory reaction,
although it resulted in an altered tendon structure.
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In 2011 Castricini et al. looked at the clinical application of platelet rich plasma
(PRP) in arthroscopic rotator cuff repairs and the corresponding results seen in those
patients that received PRP as part of their treatment.68 Platelet rich plasma is a term that
is used to cover a vast array of plasma products. The materials that make up PRP are
platelets, leukocytes, fibrin matrix, and growth factors.69 PRP is obtained from blood by
spinning blood in a centrifuge, removing the pelleted solids and using the remaining fluid
layer. It can often be activated into a gel when it comes in contact with thrombin that
polymerized the fibrinogen in solution. These authors were looking to use the PRP as a
method of growth factor augmentation at the site of a small to medium repair. They
performed 88 double row arthroscopic rotator cuff repair surgeries, 45 without PRP and
43 with PRP. The methods of comparison were Constant score and MRI imaging,
Constant score being a patient measurement of pain and functionality. All patients were
followed up at 16 months. Within each group, there was a statistically significant increase
in Constant score 16 months after surgery. However, there was not a statistically
significant difference between the PRP and no PRP groups. Via MRI, it showed that 4
patients without PRP and 1 patient with PRP showed rupture, but all were satisfied with
their clinical conditions. There was no difference shown between the tendon thicknesses
or footprint thicknesses in the two groups. In this study, the authors showed that PRP
alone was not enough to cause a significant difference between groups.
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1.5 Synthesis
From the previous research done in the area of rotator cuff repairs and tissue
engineering of tendon, it is clear that an ideal solution has yet be discovered. Although
this is the case, it is also clear that the elements of cell delivery, scaffold material, and
cell signaling must be parts of the solution. In this thesis, investigations are proposed into
a tissue engineering technique for repair of torn rotator cuff tendons that combines
aspects of previous investigations. More specifically, the proposed method includes the
use of autologous tissue, tendon tissue as scaffold, tenocytes, and adipose derived stem
cells. The combination of tailored scaffold and healthy cell source is aimed to
biologically augment the torn rotator cuff and, in doing, create a more healthily structured
repaired matrix. The tendon tissue scaffold will be used to deliver ADSCs and tenocytes
to the repair site. In addition to being used for repair, tenocytes will also be used for their
cell signaling capabilities in differentiation of the ADSCs. These cells together will then
be used to deposit new matrix and reform the extracellular matrix at the repair site.
Additionally, by using these materials and sourcing them autologously this method can
be entirely point of care. Having a point of care method means that there would be no
manipulation of materials to be implanted outside of the operating room during the
surgical timeline. By reducing the manipulation of tissue and cells to the operating room
potential for contamination of implant materials is reduced, time to repair is reduced, and
need for a secondary surgery is eliminated.
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CHAPTER TWO
PURPOSE AND AIMS
2.1 Translational Vision
The overall purpose of this project is to create a point of care biomimetic scaffold
to deliver a healthy cell source to the repair site in a massive rotator cuff tear repair. The
biomimetic scaffold will be made from autologous tendon, meshed to increase scaffold
size, surface area for cellular attachment, and cellular infiltration. The scaffold will be
seeded with autologous adipose derived stem cells, in conjugation with viable native
tenocytes residing within the autologous scaffold, as the healthy cell source.

This

construct will be fabricated during the surgical timeline using entirely autologous cells
and tissues, making it a true point of care therapy. The tendon scaffold (i.e. its ECM and
resident tenocytes) will be used to promote differentiation of the ADSCs toward a
tenocyte-like phenotype. The differentiated stem cells and tenocytes will then be capable
of creating a tendon matrix to improve tendon quality at the rotator cuff repair site. By
using native tendon as a scaffold, the tenocytes and stem cells will have a template for
creation of a properly structured tendon matrix repair.
In order to achieve our long-term goal; the feasibility of our proposed approach
needed evaluation. Thus, basic point of concept studies were undertaken to evaluate the
following;
1. The ability to reliably form macro-porous (meshed) scaffolds from a tendon
source
2. The viability of tenocytes within scaffolds
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3. The mechanical properties of the scaffold
4. The ideal autologous tenocyte source for differentiation of hADSCs
5. The ability of the scaffold-stem cell construct to integrate with underlying tissue
Therefore, within this thesis the research presented will provide an in vitro examination
of construct properties that will impact the eventual efficacy of this model for potential
implementation in an in vivo situation.

2.2 Aim 1 Description
1. Reliably form macro-porous (meshed) scaffolds from a tendon source.
2. Determine viability of tenocytes within scaffolds.
3. Evaluate mechanical properties of the scaffold.
The first goal of the overall project is to characterize the tendon autograft
scaffolds. For the investigation of this goal in this thesis, the focus was placed fabrication
of the scaffold by attempting to identify an optimal meshing/perforating system to create
the scaffold in the form of meshing. It was first necessary to determine if meshed
scaffolds could be reliably created of an appropriate size to cover a massive rotator cuff
tear repair site. Additionally, the questions of the effects of meshing were a major focus.
In terms of these meshing effects, studies were performed to determine the effects of
meshing on cellular viability and scaffold mechanical properties. These questions
comprise the first aim of this thesis, which is: “Characterize meshed tendon scaffolds”.
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2.3 Aim 2 Description
1. Determine the ideal autologous tenocyte source for differentiation of
hADSCs.
The second goal of the overall project is to determine optimal autograft scaffold
to drive stem cell differentiation. For the investigation of this goal in this thesis, it was
necessary to determine the ideal human autologous tendon source for differentiation of
adipose derived stem cells. The tendons under investigation for use in the eventual
scaffold construct include long head biceps tendon and semitendinosus tendon. Long
head biceps tendon is commonly removed during rotator cuff tear repairs through a
simultaneous biceps tenotomy. This offers a commonly discarded tissue that can be found
within the operative shoulder and could potentially be used as a tissue source for the
proposed construct. However, LHBT regularly exhibits pathology in RC repair patients.70
Such pathology consists of macroscopic degeneration, chronic inflammation, tendon
dislocation, and tendon adhesions.

18,71

Semitendinosus tendon would also represent a

potential scaffold and cell source as it is commonly used in anterior cruciate ligament
reconstruction and lacks rotator cuff pathology. These two potential sources must be
compared for their hADSC differentiation potential Therefore, the second aim for this
thesis is to “determine the optimal cell source for tenogenic differentiation of hADSCs”.
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2.4 Aim 3 Description
1. Evaluate the ability of the scaffold-stem cell construct to integrate with
underlying tissue.
The third aim of the overall project is to evaluate the efficacy of engineered
constructs to support tendon regeneration in vivo. For this thesis, all research performed
was on a preliminary level and done in vitro. However, in order to understand the
potential for bonding of the construct to underlying tissue and the differences that may
occur with and without stem cells prior to in vivo testing, integration testing was
performed in an in vitro model. This study sought to illuminate the matrix fabrication
timeline in vitro, so that it may hopefully be applied to planning future in vivo studies.
Therefore, the third aim for this thesis is: “Evaluate the construct integration with unmeshed tendon in vitro”.
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CHAPTER THREE
AIM ONE
3.1 Materials and Methods
3.11 Specimen Procurement – Porcine tendon
Porcine forelimbs were obtained from a local abattoir. All whole tissue
was washed in alternating solutions of phosphate buffered saline (PBS) + 2% antibiotic
and antimitotic (ABAM) and Betadine. Flexor and extensor digitorum tendons were
dissected out from the forelimbs and incubated at 37°C in Dulbecco’s Modified Eagle
Medium with 10% fetal bovine serum and 2% ABAM (DMEM +10%FBS +2%ABAM)
for 24 hours before use. Samples were then incubated in DMEM +10%FBS +1%ABAM
for 3 days and to monitor fungal infection prior to use.

3.12 Specimen Procurement – ST + LHBT
Long head biceps tendons and semitendinosus tendons were obtained from
patients at the time of surgery with informed consent under IRB protocol number
#Pro00031185. The long head biceps tendons were harvested from patients undergoing
rotator cuff tear repair with biceps tenotomy and the semitendinosus tendons were
harvested from patients undergoing anterior cruciate ligament reconstruction with
autologous hamstring grafting. All samples were incubated at 37°C in DMEM +10%FBS
+2%ABAM for 24 hours prior to use in order to watch for contamination of the tissue.
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3.13 Graft Scaffold Formation Optimization
Meshing optimization was performed on porcine forelimb tendon samples. Initial
testing was performed using the Zimmer™ Skin Graft Mesher with 2:1 expansion ratio
cutter and the Brennen Skin Graft Mesher with a 6:1 expansion ration cutter.

Figure 7: Zimmer™ Skin Graft Mesher with 2:1 expansion ratio cutter and 1.1mm thick
autoclavable polypropylene carrier.
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Figure 8: Brennen Skin Graft Mesher with a 6:1 expansion ratio cutter.

All non-tendinous tissue was removed including fat, muscle, and loose connective
tissue. Each tendon was cut down to approximately 2mm in thickness and measured for
actual thickness using digital calipers. Samples of varying test conditions including
compression and meshing conditions were then tested to determine the optimum meshing
conditions. Samples were tested as is in the Brennen mesher by running them through the
mesher. Conditions tested in the Zimmer mesher are noted in Table 2. Briefly,
compression coincides with running the sample through the mesher with the comb down
and without a carrier. Manual meshing coincides with running the sample through the
mesher with the comb up and with a carrier on 1.1mm thickness, wherein the user must
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remove the tendon from the cutter with forceps. Combed meshing coincides with running
the sample through the mesher with the comb down and with a carrier of 1.1mm
thickness. Sample dimensions were taken before and after each step using digital calipers.
Table 2: Combinations of meshing and compression techniques tested for meshing
optimization.
Test Compression Manual Meshing Combed Meshing
1

0

0

1

2

1

0

0

3

1

1

0

3.14 Cellular Migration
Samples of porcine tendon were cut to 1cm x 1cm sized pieces and either meshed
or left un-meshed. The meshing protocol used was determined by the previous meshing
optimization study (test 3 as seen in table 2). Tissues were cultured in 6 well plates for
14, 21, and 28 days in 3 mL DMEM +10%FBS +1%ABAM which was refreshed every 3
days. Every 7 days, the tissue was moved to another well plate and any cells attached to
the plate were trypsinized and counted to determine the number of cells that had migrated
from the tissue. At each end-point tissues were fixed in 10% neutral buffered formalin for
24 hours, embedded in paraffin, sectioned, and stained using hematoxylin and eosin
(H&E).
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3.15 Viability Testing
Semitendinosus tendon samples of 1cm x 1cm were separated into three groups
(n=2): meshed, un-meshed, and ethanol treated. Ethanol treated samples were soaked in
100% ethanol for 30 minutes prior to staining to be used as a positive control for cell
death. All samples were incubated in a live/dead working solution of 2mM calcein AM
and 4mM Ethd-1 at room temperature for 30 minutes in order to dye live cells green and
dead cells red.

3.16 Confocal Microscopy
Live/dead stained samples were imaged via laser confocal microscopy (Leica SPE
Confocal Microscope). Lasers used were at 488nm and 635nm wavelengths. Images were
averaged from three captures and taken at 600Hz speed. A 50µm deep Z-stack was
imaged for each sample. 3-D images and slice images were compiled from the resulting
fluorescent data. Three representative images from each sample were used to determine
the live/dead ratios.

3.17 Mechanical Testing
Meshed and un-meshed samples of porcine tendon measuring 30mm x 10mm
were prepared (n=9) and clamped longitudinally into a physiological saline bath mounted
on an MTS machine using a 100 N load cell. The meshing protocol used was determined
by the previous meshing optimization study (test 3 as seen in table 2). The distance
between clamps was measured with digital calipers and used as the gauge length of the

40

tissue for strain calculations. The samples were pre-conditioned to 10% strain for five
cycles and then put under tensile stress at 10mm/min until failure. The data was recorded
using the testing software (Testworks 4) in Excel and processed for elastic modulus,
ultimate tensile strength (UTS), and stiffness.

Figure 9: Image of mechanical testing set up while loading a meshed tendon sample.

3.18 Statistical Analysis
All data was presented as a mean +/- SEM (standard error of the mean). Statistical
analysis was completed using John’s Macintosh Package (JMP) software using a oneway test for variance (ANOVA) and an α of 0.05.
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3.2 Results
3.21 Meshing Optimization
Meshing of the scaffold was performed to increase the size of the tissue to fit the
size of a massive rotator cuff tear. The minimum length from anterior to posterior of a
massive rotator cuff tear is 5 cm, meaning that the width of the scaffold should be at least
that size to cover the entirety of the repair footprint.4,5,6 The length of the tear corresponds
to the width of the scaffold because the tendon tears from side to side and the scaffold
will be placed on the repair with fibers oriented in the same direction as the underlying
tendon.
Samples were tested using the Zimmer and Brennen meshers. The Brennen
mesher was tested simply by running the samples through the mesher. The Brennen
mesher comes with no comb and is a carrier free system, so this was the only method for
use of this mesher. Samples did not achieve perforation using the Brennen mesher.
Additionally, portions of the tendon tore from the sample and caught between the blades
of the cutter subsequently blocking the blades in that area from pressing into the tissue.
Since the Brennen mesher caused more destruction to the tissue than beneficial
expansion, the remaining tests and determination of expansion ratios were performed on
the Zimmer mesher. Samples were tested at each of the technique combinations shown
in Table 2. Not all of the methods provided perforation through the full thickness of the
tendon. As seen in Figure 8, test 1 (combed meshing) did not cause full perforation of the
tendon. Test 1 consists of running the sample through the mesher with the comb down
and with a carrier of 1.1mm thickness. Additionally, tendon caught in the comb during
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meshing causing many of the attempts to mesh a tendon to fail due to clogging of the
teeth. In order to ensure clogging did not occur, the tendon was pulled through using
forceps. Test 1 yielded an average of 15% expansion along the length of the tendon.

Figure 10: Tendons before and after (left to right) meshing test 1 (Table 2).

Test 2 (compression only) did not cause perforation of the tendon but did show
some increase in tendon width at the distal end, which is shown at the bottom of the
image. Test 2 consisted of running the sample through the mesher with the comb down
and without a carrier. Width was initially 60mm, but after test 2 width was measured at
110mm. This represents an expansion of 83.3%.

Figure 11: (left to right) Tendon before and after meshing test 2 (Table 2).
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Test 3, compression followed by manual meshing resulted in full perforation of
the tendon as well as expansion. Average width expansion seen using test 3 was 187%.
Test 3 consisted of running the sample through the mesher with the comb down and
without a carrier followed by running the sample through the mesher with the comb up
and with a carrier on 1.1mm thickness.

Figure 12: Images of (from left to right) un-meshed, compressed, and meshed porcine
tendons as obtained from meshing test 3 (Table 2).

The average expansion ratios for each test are shown in figure 11. The only test
that created both full perforation in the scaffold and surpassed the 100% expansion
expected for the 2:1 cutter was test 3. Although the results were variable in expansion
ratio, the lowest expansion ratio seen with test 3 was still higher than the advertized
expansion ratio of the mesher. The higher than advertised expansion indicates that there
is a potential to increase the expansion even further if needed with the use of higher
expansion ratio cutters. This is beneficial in fabricating scaffolds for massive rotator cuff
tears, as they do not have a maximum size but there is theoretically a maximum tissue
volume that one patient can give as autograft (as determined by the surgeon).
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Figure 13: Graph indicating the expansion ratios obtained via tested meshing protocols.

3.22 Cellular Migration
After meshing the tendons to create scaffolds, it was necessary to determine the
effects that said meshing had on the cells within the tendon. Therefore, initial viability
assessments were performed in the form of this cellular migration study. Histologically,
all day 14 samples showed well-dispersed nuclei throughout the tissue regardless of
meshing. By day 28, the nuclei had concentrated at the edges of the tissue. This pattern
followed in both meshed and un-meshed tissues. Cells therefore were migrating towards
the edges or the outsides of the tissue in both meshed and un-meshed groups.
Cellular migration out of meshed and un-meshed tendons was compared at 14, 21,
and 28 days. There were no statistically significant differences seen between meshed and
un-meshed at any time point. The highest number of cells counted on the plates occurred
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in both groups at day 14 and decreased in number over time following that time point.
Although the difference between cell counts was not statistically significant, values did
trend toward lower cell numbers when the tissues were meshed.

Figure 14: Top: cell migration after meshing compared to un-meshed porcine tendon as
seen in histological imaging. Pink areas in histological images show extracellular matrix
and dark blue dots are cell nuclei. Nuclei remain dispersed in both samples at day 14 but
focus along the tissue edge at day 28. Bottom: graph indicating the number of cells
vacating the tissue (per unit volume of tissue) for meshed and un-meshed tissue at days
14, 21, and 28.
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3.23 Direct Assessment of Viability
Following cellular migration studies, which indicated a potential cellular decrease
in meshed tissue, a direct assessment of cellular viability in the form of a live/dead assay
was required. Using the confocal images taken of live/dead stained cells, viability was
determined. Live cells were stained green while dead cells were stained red. All ethanol
samples, as a positive control for cell death, resulted in 100% cell death. Un-meshed and
meshed tendon samples had averages of 31% and 61% death respectively. All differences
in cell death were statistically significant. Between un-meshed and meshed tendon
samples, there was a 30% decrease in cellular viability seen. Through the 3-D rendering
of the confocal images, it is clear that live/dead ratios remained approximately the same
throughout the density of the tendon samples.
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Figure 15: Single section (A, B, C) and 3-D (D, E, F) confocal images of semitendinosus
tendon stained for viability. Green cells are live and red cells are dead. A, D: Un-meshed
tendon showed the highest percentage of live cells, with some dead cells still present. B,
E: Meshed tendon showed a higher concentration of dead cells than un-meshed tendon.
C, F: All cells within the ethanol treated samples were stained as dead.
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Figure 16: Semi-quantitative calculations of cell death due to meshing in semitendinosus
tendon as determined by live/dead staining.

3.24 Mechanical Testing
Tendons are capable of withstanding high amounts of stress prior to failure in
normal conditions, however the meshing of a tendon to create a scaffold alters the
connectivity between the fibers of the extracellular matrix. This alteration was likely to
alter the mechanical properties of the tendon; therefore it was necessary to perform
mechanical testing on meshed and un-meshed tendon tissues to determine the change
seen due to meshing. Stress/strain graphs were created for each tensile test performed.
Meshed samples exhibited lower ultimate tensile stress than un-meshed samples, with
graphs peaking at lower values on average (0.56 MPa for meshed, 2.38 MPa for
unmeshed). Conversely, meshed samples exhibited increased deformation prior to
breakage than un-meshed tissues. Meshed tissues yielded at 60.6% strain and un-meshed
tissues yielded at 28.4% strain. Elastic modulus and stiffness were also calculated from
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the stress/ strain curves. The elastic modulus of un-meshed tendon was significantly
higher than that of meshed tendon with calculated values of 37.17 MPa and 4.72 MPa
respectively. There was not a statistical difference between the stiffness values calculated
for meshed and un-meshed tendon. This indicates that stiffness is the only material
property of tendon that remains unchanged due to meshing.
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Figure 17: Representative stress-strain curves for meshed and un-meshed tendon samples
under tension.
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Figure 18: Graph of elastic moduli of meshed and un-meshed tendons. Un-meshed
tendons have a statistically larger modulus than meshed tendons.
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Figure 19: Graph of stiffness values of meshed and un-meshed tendons.
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Figure 20: Graph of ultimate tensile strength (UTS) values of meshed and un-meshed
tendons. The UTS of un-meshed tendon is significantly higher than that of meshed
tendon.

3.3 Discussion
3.31 Meshing Optimization
In order to fabricate this construct, the ideal meshing technique must be
determined. The ideal meshing technique was determined by finding a technique that
required few manipulations of the tendon, created a clean mesh, and created a reliably
expanded mesh. Using a skin graft mesher to perforate a tendon scaffold requires
alterations of the normal use protocol. A skin graft mesher was chosen because it is
already approved by the FDA for manipulation of skin tissue, is easily cleanable and
sterilizable, and is designed to create expandable meshes from soft connective tissues.
For example, the normal use of the mesher called for leaving the comb in place to remove
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tissue from the teeth of the cutter. However, when meshing a tendon the comb caused
back up of meshed tendon within the teeth leading to shredding and clogging of the
mesher. By meshing with the cutter and without a carrier to force the tissue into the
blades, only compression of the tissue was achieved. This compression did expand the
width of the tissue, but it did not allow for perforation by the cutter blades. The third
method tested, using compression to initially increase the width of the tissue followed by
meshing without the comb to allow for easier extraction, yielded the best-constructed and
most highly expanded scaffolds. The advertised expansion ratio of 2:1, or 100%
expansion, was surpassed by the third method with an average of 187% expansion. This
increase in expansion likely occurred due to the combination of the expansion from
compression, which under test 2 caused an average of 83.3% expansion, and the
perforation from mechanical meshing, which likely added the advertised 100%
expansion. This will allow for larger scaffolds from less tissue, so that a massive tear of
50mm could be covered by a sample of the initial width of 17.4mm.

3.32 Cellular Migration
Following meshing optimization, it was next necessary to determine the effects of
the chosen meshing method on the scaffold. Tenocytes within the meshed tendons and
un-meshed tendons migrated from the scaffolds. Within both groups, the pattern of
migration appeared at the same times histologically. Although the numbers of cells that
migrated from the tendons were similar, there was a trend towards a decrease in cell
number after meshing. This was seen as an indicator of potential cell death and therefore
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a need to perform direct viability studies. This, however, is not a measurement of cellular
viability as cellular mobility and proliferation may have contributed to the overall cell
numbers.
Since tendon is a dense connective tissue, it is likely that the media was unable to
fully penetrate the tissue. Therefore, tenocytes likely migrated to reach areas of higher
nutrient concentration. This cellular crawl-out has been used by many researchers as a
method for isolation of tenocytes.58,72,73 This information could be used to further study
the potential to direct the location of cells within the construct via nutrient concentration,
potentially using a nutrient dense biologic such as PRP. This would be beneficial for the
project’s next steps because mobilizing tenocytes increases the potential number of cells
acting at the surgical repair interface and increases the likelihood of hADSC to tenocyte
contact.

3.33 Direct Assessment of Viability
Meshing of ST tendon causes a notable decrease in viable tenocytes within the
tendon scaffold but does not kill all of the cells within the scaffold. There is a 30%
decrease in cellular viability between meshed and un-meshed tendons. However, it can be
seen from the confocal images in figure 10 that the morphology of meshed tendon
tenocytes remain aligned and spindle shaped.
The concentration of cells within a tendon is low compared to other tissue types
(<5% of the total volume), and further decreased by the meshing process it remains to be
seen if the remaining concentration will be sufficient for the differentiation of hADSCs
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and the fabrication of ECM.32 Future studies within this overall project goal should focus
on determining the ideal concentrations of hADSCs and tenocytes for tendon hADSC
differentiation and ECM regeneration.

3.34 Mechanical Testing
Many tendon scaffolds are used as mechanical augmentation for a repair site.41,74
However, with the significant decrease in ultimate tensile strength (UTS) and young’s
modulus seen with meshing this proposed construct must only be used as a biological
augmentation. This limitation of mechanical strength may lead to the potential use as a
biological augmentation to be used with current mechanical augmentations in use. It is
also yet to be seen how cellular activity affects the mechanical properties of the meshed
scaffold. In order to determine the biological augmentation benefits of the scaffold, later
mechanical testing should be done to determine if cellular culture would increase the
mechanical properties measured herein. In ECM were to be deposited by resident and
applied cells, it could change the mechanical properties from those reported.
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CHAPTER FOUR
AIM TWO
4.1 Materials and Methods
4.11 Specimen Procurement –ST + LHBT
Long head biceps tendons and semitendinosus tendons were obtained from
patients at the time of surgery with informed consent under IRB protocol Pro00031185.
The long head biceps tendons were harvested from patients undergoing rotator cuff repair
with tenotomy and the semitendinosus tendons were harvested from patients undergoing
anterior cruciate ligament reconstruction with autologous grafting. All samples were
incubated at 37°C in Dulbecco’s Modified Eagle Medium with 10% fetal bovine serum
and 2% antibiotic antimitotic (DMEM +10%FBS +2%ABAM) for 24 hours prior to use
in order to watch for contamination of the tissue.

4.12 Cell Isolation
Semitendinosus and long head biceps tendon tissues were cut to 10mm x 10mm x
2 mm, meshed using a skin graft mesher (Zimmer) as determined by the meshing
optimization trial (test 3 as seen in table 2). The tissue samples were then cultured in a 6
well plate in 3 mL DMEM +10%FBS +1%ABAM that was refreshed every 3 days.
Adherent tenocytes were harvested after 14 days. Samples were left in culture and
additional adherent cells were harvested again at day 21. Cells were then expanded in
monolayer culture for further use. Human adipose derived stem cells (hADSCs) were
purchased from Invitrogen. Passage 4 tenocytes and stem cells were used in all studies.
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4.13 Indirect Co-Culture
Indirect co-culture of human tenocytes and hADSCs was performed via
conditioned media transfer. 2x105 long head biceps tenocytes or semitendinosus
tenocytes, and hADSCs were cultured in individual T25 flasks. Tenocytes were cultured
with 5mL of DMEM +10%FBS +1%ABAM that was removed and refreshed every 3
days. Media taken from the tenocyte cultures every 3 days was sterile filtered and given
to the hADSCs in a 50:50 volumetric ratio with fresh media (n=3) to a total of 5 mL. This
method transferred any cellular excretions from the tenocytes to the hADSCs through the
media.

4.14 RT-PCR
RNA was isolated from hADSCs using an RNEasy Mini Kit (Qigen) in
accordance with the protocol provided by the manufacturer and then quantified after 14
and 21 days of culture (n=3). Quantification of RNA was performed using a nanodrop
spectrophotometer. A sample of un-conditioned hADSCs at day 0 was used as a control.
A tenocyte gene transcript profile was evaluated using the target specific primers in table
3 was evaluated for use as a housekeeping gene. Reverse transcription and real time
polymerase chain reaction (RT-PCR) was performed using a RETROscript and
QuantiTect SYBR green PCR kit in a Rotogene 3000 thermocycler. Data was analyzed
using the 2-ΔCT method with GAPDH as an internal control. Normalized expression was
determined by using 2-ΔCT of the sample / 2-ΔCT of the GAPDH control.
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Table 3: Target specific primers for tenocytes with their corresponding forward primer
sequences.
Primer

Sequence

Collagen I (COL I)

5’ GGCTCCTGCTCCTCTTAGCG 3’

Collagen III (COL III)

5’ CAGCGGTTCTCCAGGCAAGG 3’

Scleraxis (SCX)

5’ ACACCCAGCCCAAACAGA 3’

Tenascin C (TNC)

5’ GGTGGATGGATTGTGTTCCTGAGA 3’

GAPDH

5’ CAAGGCTGAGAACGGGAAGC 3’

4.15 Statistical Analysis
All data was presented as a mean +/- SEM (standard error of the mean). Statistical
analysis was completed using John’s Macintosh Package (JMP) software using a oneway test for variance (ANOVA) and an α of 0.05.

4.2 Results
Expression of collagen I, collagen III, scleraxis, and tenascin C markers were
compared for hADSCs differentiated in semitendinosus or long head biceps tendon
tenocyte conditioned media. hADSC gene expression was measured at days 14 and 21 as
compared to a day 0 undifferentiated hADSC control. Semitendinosus conditioned cells
showed an increasing trend in all markers over time, whereas long head biceps tendon
conditioned cells held a relatively steady expression over time. Results found were not
statistically significant in any marker group. There was a trend towards higher expression
over time in the ST group for all markers.
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Figure 21: Graphs of tenocyte gene expression seen in hADSCs (collagen I, collagen III,
scleraxis, and tenascin C) with respect to GAPDH and an un-differentiated control.

4.3 Discussion
Autologous tendon sources that are available for use for rotator cuff repair are
relatively limited. Authors have previously used long head biceps tendon for its
proximity to the surgical site and frequent removal after transection during biceps
tenotomy.18,48 However, the noted pathologies seen in the biceps tendon in patients with
rotator cuff injuries such as macroscopic degeneration, chronic inflammation, tendon
dislocation, and tendon adhesions can be a cause for reconsideration of this tendon
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source.18,48 The semitendinosus tendon is commonly used as both autograft and allograft
for ACL reconstruction and comes from outside the damaged rotator cuff environment.
Therefore, I compared these two tendon sources to determine if the reported pathologies
of the long head biceps tendon would affect their potential to differentiate hADSCs. Coculture between tenocytes and hADSCs for the differentiation of hADSCs has been
shown as feasible by many investigators.58,60,73 Kraus et al. demonstrated the feasibility of
direct, indirect, and media-based co culture methods between tenocytes and stem cells.57
The resulting gene expression data showed that expression of tenogenic markers
in hADSCs differentiated using long head biceps tendons remained static over time.
Those hADSCs differentiated by semitendinosus tendons, however, showed an increasing
trend over time in each of the markers measured. This difference in expression combined
with the potential for macroscopic degeneration of the biceps tendon indicated that
semitendinosus tendon would likely be the ideal tendon scaffold for this project.
Future studies with gene expression would include determination of the ideal
tenocyte to hADSC ratio for differentiation as well as the effects of the scaffold itself on
the gene expression of hADSCs.
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CHAPTER FIVE
AIM THREE
5.1 Materials and Methods
5.11 Cell staining
Adipose derived stem cells were stained with PKH26 red fluorescent marker (cell
linker kit from Sigma-Aldrich). Cell staining began by pelleting 2x106 hADSCs via
centrifugation and re-suspending them in 100 µL Diluent C, from the cell linker kit.
Following re-suspension, the dye solution was made by combining an additional 100 µL
Diluent C with 1 µL of the ethanolic dye solution and vortexing them to combine. The
dye solution was then added to the cell suspension, mixed via pipetting, and then
incubated at room temperature away from light for 5 minutes. After 5 minutes of
incubation, 200 µL FBS was added, mixed via pipetting, and incubated away from light
for 1 minute to bind excess dyes. The cell solution was then centrifuged down to a pellet,
re-suspended in 10 mL complete media, and re-centrifuged to remove any remaining
dyes. The stained cells were then seeded onto meshed porcine tendon scaffolds and
cultured for 21 days. After 21 days, the samples were imaged under fluorescent
microscopy to determine cellular attachment and alignment with scaffold matrix. PKH26
is a lipophilic membrane marker that has excitation and emission peaks at 551nm and
567nm respectively. Therefore, the fluorescent filter for red fluorescent protein (RFP)
was used to visualize the cells.
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5.13 Integration Study
Porcine tendons were meshed to create scaffolds and cut to 10mm x 10mm in
size. The meshed scaffolds were then soaked in 49% DMEM + 50% FBS + 1% ABAM
for two hours. Following the findings from the cellular migration study in Aim 1,
artificially increasing the nutrient content within the scaffold by soaking it in a higher
concentration of FBS should keep the cells from migrating out of the tissue to reach the
surrounding media. The scaffolds were then seeded with 2.0x105 human adipose derived
stem cells. Un-meshed tendon of 10mm x 10mm x 2mm were submerged halfway in FBS
for 2 hours to create a higher nutrient content in the tissue than would be present within
the surrounding media. This was done, based on the findings from the cellular migration
study in Aim 1, to drive the cells within the tissue to the interface. Each scaffold was then
sutured to the FBS soaked face of an un-meshed tendon using a single simple suture at
each end. The construct was plated in a 6 well plate with the scaffold on top of the unmeshed tendon and cultured for 14 or 21 days (n=3) in DMEM +10%FBS +1%ABAM.
Media was refreshed every 3 days. Control samples were constructed as previously
described but without the addition of stem cells (n=3).

Figure 22: Schematic of integration study constructs. Meshed tendon is fixed on top of
un-meshed tendon. Blue circles represent tenocytes and red triangles represent hADSCs.
Sizes of components are not to scale.
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Figure 23: Images of experimental constructs used to determine suture placement and
fixation method in integration study. Samples are 4x length of the final scaffolds, two
pieces of 2mm thick porcine tendon, and connected using a single simple suture at each
end.

5.14 Histology
Samples were fixed in 10% neutral buffered formalin for 24 hours, embedded in
paraffin, sectioned, and stained using hematoxylin and eosin (H&E) and picrosirius red.
Samples were imaged at 100x and 200x under a light microscope in order to locate the
integration line.

5.2 Results
PKH26 stained hADSCs were seen to migrate into the meshed tendon scaffold
onto which they had been seeded. Figure 17 shows the hADSCs aligned within the
tendon matrix.
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Figure 24: Fluorescent image of PHK26 stained hADSCs within a tendon matrix after 21
days of culture.
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Figure 25: Histological images of meshed and un-meshed tendons at their integration
sites stained with H&E. ECM is stained pink and nuclei are stained dark blue. A, B)
Meshed tendon with hADSCs at day 14 (50x, 200x). C, D) Meshed tendon without
hADSCs at day 14 (50x, 200x). E, F) Meshed tendon with hADSCs at day 21 (50x,
200x). G, H) Meshed tendon without hADSCs at day 21 (50x, 200x). Cells at the
integration zones are noted with black arrowheads in 200x images.

When imaged, the integration border between meshed and un-meshed tendon is
visible in all histological samples, though less easily discerned in those samples seeded
with hADSCs stained with H&E. At day 14, hADSC seeded samples show a line of
higher tissue density between two distinct tissue textures, suspected to be the interface.
At the top of this interface, where the tissues come together, a collection of cell nuclei are
seen between the two edges. Additionally, in the area where the edges of the two tissues
have not met, cell nuclei are seen to line the borders of each tissue. At day 21, hADSC
seeded samples show a less discernable border as there is no line of higher cell or tissue
density where the tissues connect. The tissue fibers appear to blend the tissues together
without a distinction between the two. There is still an area where the two tissues do not
connect, but this is likely due to poor fixation during culture allowing space between the
scaffold and underlying tendon.
In those samples that did not receive hADSCs a border can be seen between a
very dense un-meshed tissue and a more loosely fibrous meshed tissue day 14. The two
tissues do appear close together at their borders but there does not appear to be
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integration between the two tissues at the edge. Along the un-meshed edge there is a
higher density of cells, but they do not appear to be interacting with the adjacent tissue.
At day 21, tissues without stem cells had a significantly difference appearance from other
tissue groups. There are clear lines where the edges of tissue used to be, appearing more
similarly to the day 14 stem cell seeded group, but missing the line of higher density
matrix. Cells seen at the edge of the un-meshed tissue do appear to be creating bonds
with the scaffold, as thin lines of matrix can be seen extending from a cell on the unmeshed tissue toward the scaffold.

5.3 Discussion
This study aimed to determine how our proposed scaffold system would
potentially fuse with native tendon in an in vitro model. Integration, or the combining of
the scaffold in the body of the native tendon, is essential because it represents both
cellular activity in reconstruction of tendon and a physical augmentation at the repair site.
Stained cells were seeded onto meshed tendons in order to determine if they would
migrate into the scaffold and align properly with the matrix. This migration is important
because the goal for the seeded hADSCs is for them to inhabit the entirety of the scaffold
or underlying tendon and eventually create a bond with the injured tendon surface
For this study we sought to determine how stem cells at the interface of the repair
site would interact with the scaffold and the tendon. Therefore, in this study, the hADSCseeded surface was in contact with the un-meshed tendon. Additionally, for this study we
soaked meshed scaffolds in an increased concentration of FBS prior to seeding. We
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determined in previous studies that cellular crawl-out of the tissue was likely due to low
nutrition at the core and higher nutrition within the plate as a whole. Therefore, be
soaking the tendon in FBS prior to seeding, we simulate an environment in which the
tendon is properly supplied with nutrients during the migration process. Upon seeing
histological results, they indicated that cells were driven to the interface by day 14 in both
stem cell seeded and un-seeded groups by the FBS soaking method employed. The use of
FBS in this study led us to consider the further use of PRP in our model as a method of
concentrating cells at a given surface area and drawing stem cells and tenocytes from the
scaffold to the injury site for repair purposes. Since PRP gelates in vivo, it would remain
in place at least temporarily as a signaling guide for the movement of cells within the
tissue.
The integration of the two tissues was relatively similar between groups, but it did
seem as though the groups containing hADSCs reached a more complete level of
integration faster than those without hADSCs. This indicates that hADSCs may not be
strictly necessary for the integration of scaffold and tissue, but they do increase the speed
of the process. Additionally, the day 21 samples without stem cells seemed to be very
weakly connected. This follows the pattern that tenocytes initially heal tendon by using
insufficiently strong scar tissue. At day 21, the samples with hADSCs appeared to have
similar ECM structure throughout which would not cause a weak spot within the tendon.
This could be tested in future by repeating the study and performing mechanical testing
on the resulting integrated scaffold constructs.
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CHAPTER SIX
CONCLUSIONS
Within this thesis several initial elements of a long-term project on the biological
augmentation of rotator cuff repair were investigated. Optimization the fabrication of a
meshed tendon scaffold for biological augmentation was performed using a skin graft
mesher. The resulting construct was then investigated for mechanical properties and
determined to have a significant change in those properties due to meshing. It was
demonstrated that ST tendon is capable of maintaining limited cellular viability and
mobility towards nutrients after meshing for the formation of an autologous scaffold.
Additionally gene expression results indicate that tendon sources from differing areas of
the body have varying hADSC differentiation potential. Due to a pattern of increases in
hADSC differentiation and sufficient viability after meshing, ST tendon has been chosen
as the autologous tendon source for use in this proposed application. Finally, the
integration patterns of meshed scaffolds with un-meshed tendons follow the hypothesis
that hADSCs would increase the quality of tendon tissue at a repair site in vitro.
Future studies for this project should include mechanical testing of in vitro
integration models as well as implementation of an in vivo model for integration of this
scaffold at a repair site. For a point of concept of tendon integration, this in vivo study
could be performed on any tendon not necessarily in the rotator cuff. Additionally,
studies into the ideal hADSC to tenocyte ratio should be performed to determine ideal
repair conditions.
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